Highlights and Progress｜Impact Investment Initiative for Global Health (Triple I for GH)

Major Events and Other Outreach Events

Since its launch on the occasion of 78th UN General Assembly, the initiative has organized side events and engaged in various outreach activities to increase the visibility of impact investing in global health. With the support of many stakeholders, the number of Triple I partners has been steadily increasing.

Two Working Groups to achieve our mission

Triple I for GH has established two Working Groups based on its mission. The Working Groups have discussed the topics in greater depth with experts and professionals.

Working Group on Impact Management and Measurement (Sep. 2024 ~)

This Working Group was established to support the development of models for impact investing, especially to promote the harmonization of existing Impact Measurement and Management (IMM) practices. The WG is planning to develop a Practitioner Guide and policy recommendations. These documents will be available on our website once it is published.

Working Group materials ＜partner-only＞

Working Group on Policies and Enabling Environments (Sep. 2024 - Jan. 2025)

This Working Group, having members from DFIs, MDBs, impact investors, and philanthropic organizations, was established to gather valuable insights from different stakeholders on useful policy tools to promote impact investing. The summary of the discussions of the WG has been published as Recommendations for policy makers issued at the side event in Davos in 2025.

Learn more about the Triple I for GH activities: Triple I Annual Report: September 2023 - September 2024; Triple I Midterm Report: September 2023 - May 2024

Analysis of the Current Landscape of Impact Investing

Triple I partners reported USD 22.4 billion for ongoing activities as of 2023 global health impact investments in LMICs, including low-income populations (87% of all projects), with Africa leading in project count.¹
Despite varied IMM practices, there's a trend towards robust measurement, which will shape future best practices and guidance for impact investing in health as Triple I continues to gather data annually

Global Health Investment State.

Out of USD 22.4 billion, 93% (USD 20.9 billion) is in investments and 6% (USD 1.4 billion) is in projects.
The private sector contributed 80% of the capital, while public sources provided the remaining 20%.

Investment Capital is reaching Low-Income and Vulnerable Populations

The majority of Triple I's investments/projects in 2023 include low-income or vulnerable populations, with USD 19.5 billion (87.1% of total) of the total funds including these groups. In contrast, only 12.9% targeted upper or middle-income beneficiaries, accounting for USD 2.9 billion of the funding.

Share of investments/ projects that include

The low-income or vulnerable population-specified investments and projects in 2023 reach to USD 1.6 billion (7.1% of total), with breaking down to USD 0.9 billion for the investments and USD 0.6 billion for projects accordingly.

Investment/Project Targeting Only Lower or Poor and Vulnerable Group（Amount）

Health Systems Lead among Areas of Investment for Partners

Across Triple I is primarily concentrated in three areas: "Health systems", "Diseases and conditions", and "Health interventions", reﬂecting the tackling of both structural gaps and the coronavirus crisis.
Hospitals, medical devices, coronavirus disease, HIV, medicines, and vaccines and health economics are prevalent sub-topics being addressed by investments. Other topics such as WASH, women's health and digital health also rank in the top 10.

Healthcare Service Delivery Emerges as Primary Impact Channel

According to the data reported by partners of Triple I, projects/investments have had following impact.

Number of projects by country

While partner data shows geographic diversiﬁcation overall, some markets present a high number of investments/projects, such as India (18 cases), Kenya (18 cases) and Nigeria (13 cases). This geographic focus will be the object of further analysis in the future.